180 related articles for article (PubMed ID: 12177805)
21. Identification of a panel of complex autoantigens (LGALS3, PHB2, MUC1, and GK2) in combination with CA15-3 for the diagnosis of early-stage breast cancer.
Zuo X; Chen L; Liu L; Zhang Z; Zhang X; Yu Q; Feng L; Zhao X; Qin T
Tumour Biol; 2016 Jan; 37(1):1309-17. PubMed ID: 26289852
[TBL] [Abstract][Full Text] [Related]
22. [Screening tumor antigens of ovarian carcinoma by Western blot, immunoprecipitation, and mass spectrometry].
Liu B; Yang JL; Song X; Huang X; Kan B; Qin H; Wen YJ; Zhao X; Wei YQ
Ai Zheng; 2005 Jul; 24(7):890-2. PubMed ID: 16004822
[TBL] [Abstract][Full Text] [Related]
23. Anti-heat shock protein autoantibody profiling in breast cancer using customized protein microarray.
Shi L; Gehin T; Chevolot Y; Souteyrand E; Mangé A; Solassol J; Laurenceau E
Anal Bioanal Chem; 2016 Feb; 408(5):1497-506. PubMed ID: 26715250
[TBL] [Abstract][Full Text] [Related]
24. Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancer.
Tang L; Yang J; Ng SK; Rodriguez N; Choi PW; Vitonis A; Wang K; McLachlan GJ; Caiazzo RJ; Liu BC; Welch WR; Cramer DW; Berkowitz RS; Ng SW
Eur J Cancer; 2010 Jan; 46(1):170-9. PubMed ID: 19926475
[TBL] [Abstract][Full Text] [Related]
25. Chemiluminescent optical fiber immunosensor for detection of autoantibodies to ovarian and breast cancer-associated antigens.
Salama O; Herrmann S; Tziknovsky A; Piura B; Meirovich M; Trakht I; Reed B; Lobel LI; Marks RS
Biosens Bioelectron; 2007 Feb; 22(7):1508-16. PubMed ID: 16904309
[TBL] [Abstract][Full Text] [Related]
26. Concentrations of antibodies against heat shock protein 27 in the sera of women with ovarian carcinoma.
Olejek A; Damasiewicz-Bodzek A; Bodzek P; Wielkoszyński T; Zamłyński J; Stołtny P; Skutil M
Int J Gynecol Cancer; 2009 Dec; 19(9):1516-20. PubMed ID: 19955928
[TBL] [Abstract][Full Text] [Related]
27. Selenium-Binding Protein 1 (SBP1) autoantibodies in ovarian disorders and ovarian cancer.
Yu-Rice Y; Edassery SL; Urban N; Hellstrom I; Hellstrom KE; Deng Y; Li Y; Luborsky JL
Reproduction; 2017 Mar; 153(3):277-284. PubMed ID: 27965399
[TBL] [Abstract][Full Text] [Related]
28. [Clinical study of autoantibody spectrum against ovarian cancer associated antigens combined with CA(125) in detecting and monitoring ovarian cancer].
Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L
Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):113-8. PubMed ID: 21426769
[TBL] [Abstract][Full Text] [Related]
29. Autoantibody biomarkers identified by proteomics methods distinguish ovarian cancer from non-ovarian cancer with various CA-125 levels.
Karabudak AA; Hafner J; Shetty V; Chen S; Secord AA; Morse MA; Philip R
J Cancer Res Clin Oncol; 2013 Oct; 139(10):1757-70. PubMed ID: 23999876
[TBL] [Abstract][Full Text] [Related]
30. Identification of Tumor Antigens in Ovarian Cancers Using Local and Circulating Tumor-Specific Antibodies.
Da Gama Duarte J; Quigley LT; Young AR; Hayashi M; Miyazawa M; Lopata A; Mancuso N; Mikami M; Behren A; Meeusen E
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681879
[TBL] [Abstract][Full Text] [Related]
31. Serum Anti-PDLIM1 Autoantibody as Diagnostic Marker in Ovarian Cancer.
Qiu C; Duan Y; Wang B; Shi J; Wang P; Ye H; Dai L; Zhang J; Wang X
Front Immunol; 2021; 12():698312. PubMed ID: 34489945
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays.
Chatterjee M; Mohapatra S; Ionan A; Bawa G; Ali-Fehmi R; Wang X; Nowak J; Ye B; Nahhas FA; Lu K; Witkin SS; Fishman D; Munkarah A; Morris R; Levin NK; Shirley NN; Tromp G; Abrams J; Draghici S; Tainsky MA
Cancer Res; 2006 Jan; 66(2):1181-90. PubMed ID: 16424057
[TBL] [Abstract][Full Text] [Related]
33. Expression of heat-shock proteins hsp27, hsp70 and hsp90 in malignant epithelial tumour of the ovaries.
Elpek GO; Karaveli S; Simşek T; Keles N; Aksoy NH
APMIS; 2003 Apr; 111(4):523-30. PubMed ID: 12780528
[TBL] [Abstract][Full Text] [Related]
34. Identification of tumour antigens by serological analysis of cDNA expression cloning.
Li G; Miles A; Line A; Rees RC
Cancer Immunol Immunother; 2004 Mar; 53(3):139-43. PubMed ID: 14722670
[TBL] [Abstract][Full Text] [Related]
35. Serum levels and biochemical characteristics of human ovarian carcinoma-associated antigen defined by murine monoclonal antibody, CF511.
Ohkawa K; Tsukada Y; Murae M; Kimura E; Takada K; Abe T; Terashima Y; Mitani K
Br J Cancer; 1989 Dec; 60(6):953-60. PubMed ID: 2605105
[TBL] [Abstract][Full Text] [Related]
36. Plasma heat shock protein 90-alpha have an advantage in diagnosis of colorectal cancer at early stage.
Kasanga M; Liu L; Xue L; Song X
Biomark Med; 2018 Aug; 12(8):881-890. PubMed ID: 29939072
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.
Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY
Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480
[TBL] [Abstract][Full Text] [Related]
38. Elevated levels of the 90 kDa heat shock protein (hsp90) in SLE correlate with levels of IL-6 and autoantibodies to hsp90.
Ripley BJ; Isenberg DA; Latchman DS
J Autoimmun; 2001 Dec; 17(4):341-6. PubMed ID: 11771959
[TBL] [Abstract][Full Text] [Related]
39. Autoimmunity to the M(r) 32,000 subunit of replication protein A in breast cancer.
Tomkiel JE; Alansari H; Tang N; Virgin JB; Yang X; VandeVord P; Karvonen RL; Granda JL; Kraut MJ; Ensley JF; Fernández-Madrid F
Clin Cancer Res; 2002 Mar; 8(3):752-8. PubMed ID: 11895905
[TBL] [Abstract][Full Text] [Related]
40. Utility of paraneoplastic antigens as biomarkers for surveillance and prediction of recurrence in ovarian cancer.
Chatterjee M; Hurley LC; Levin NK; Stack M; Tainsky MA
Cancer Biomark; 2017 Dec; 20(4):369-387. PubMed ID: 29125478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
